Delivery Order SPE2DB20D7059-SPE2DB24FQGF8
Award Date 6/5/24
Potential Completion Date 6/6/24
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $4,389.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of Doxepin Hydrochloride 3 mg tablets. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of...
- This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Doxepin Hydrochloride 3 mg tablets to support the Defense Logistics Agency (DLA) Troop Support Medical program. The firm-fixed-price delivery order, valued at $1,815.47, has an ultimate completion date of December 6, 2024. Amerisourcebergen is the prime contractor, and there is no set-aside designation mentioned. This award is part of a larger Indefinite Delivery Contract (IDC)...
- This federal contract award, issued by the Defense Logistics Agency (DLA) Troop Support Medical, is a Firm Fixed Price Delivery Order worth $7,131.37. It was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on September 22, 2023. The contract covers the delivery of Doxepin HCL 3mg Tablets in quantities of 30s, with a completion date of September 25, 2023. Amerisourcebergen is the prime contractor on this award and holds a significant...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of Doxepin HCL 3 mg tablets. The fixed-price, firm-fixed delivery order has a ceiling value of $2,261.61 and an ultimate completion date of March 4, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of Doxepin HCL 3 mg tablets in 30-count packages, with a ceiling value of $1,751.01 and a completion date of March 29, 2024. The contract is a firm fixed price delivery order, which is part of a larger indefinite delivery contract...
- This federal contract award, valued at $2,079.61, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Doxepin HCL 3 mg tablets, a medication used to treat various mental health conditions. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,449.61, is for the supply of Doxepin Hydrochloride 3 mg tablets to support military and federal healthcare programs. The contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to provide Doxepin HCL 3 mg tablets. The contract has a ceiling value of $2,467.05 and a period of performance through April 2, 2024. AmerisourceBergen Drug Corp is the prime contractor and has no set-aside designation. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to...
- This federal contract award is for the delivery of 3mg doxepin hydrochloride tablets to the Defense Logistics Agency (DLA), a defense agency. The $1,057.62 fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 25, 2024, with a completion date of June 26, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
- This federal contract award, valued at $3,442.16, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of Doxepin HCL 6 mg tablets to support military and federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 through...